Rapiscan
·
- Prescription status not stated
- Heart, blood pressure and circulation
- Active substance
- Regadenoson
- Made by
- GE Healthcare AS
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
- This medicinal product is for diagnostic use only. Rapiscan is a selective coronary vasodilator for use as a pharmacological stress agent for radionuclide myocardial perfusion imaging (MPI) in adult patients unable to undergo adequate exercise stress.
From the official label · 2026-09-30 · European Medicines Agency
Same active substance, strength and form in other countries
Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.
Medicine passport: one printable page to show a pharmacist abroad
United StatesNo exact match for this strength and form
SpainNo exact match for this strength and form
NetherlandsNo exact match for this strength and form
SwitzerlandNo exact match for this strength and form
Details
| Made by | GE Healthcare AS |
|---|---|
| Active substance | Regadenoson |
| Used in | Heart, blood pressure and circulation |
| Classification | C01EB21 · Heart, blood pressure and circulation |
| Authorised on | 2010-09-06 |
| Last updated by the regulator | 2025-12-17 |
| EMA product number | EMEA/H/C/001176 |
Source: European Medicines Agency — medicine data · 2026-09-30 · not reviewed by a clinician
Source: European Medicines Agency (EMA). Product information as published by EMA. Reuse terms: EMA legal notice (reproduction authorised).